Neumora Therapeutics announced the appointment of Kaya Pai Panandiker as CCO and a member of Neumora’s executive team.
Neumora Therapeutics, a clinical-stage biopharmaceutical company redefining neuroscience drug development, announced the appointment of Kaya Pai Panandiker as chief commercial officer and a member of Neumora’s executive team, reporting to Henry Gosebruch, president and CEO. “I am excited to welcome…